Selank
Selank (TP-7)
Selank is a synthetic heptapeptide analog of the immunomodulatory peptide tuftsin, developed at the Russian Academy of Sciences. It is approved in Russia as a prescription treatment for generalized anxiety disorder and asthenic conditions. Research has focused on its effects on GABA receptor modulation, serotonin metabolism, BDNF expression, and immune signaling through its tuftsin-derived structure. Research dosing is typically 200–500mcg twice daily via intranasal spray or subcutaneous injection in 2–4 week cycles. Researchers monitor cortisol, BDNF (when available), and subjective stress and anxiety scores as the primary response markers.
Typical dose
300mcg
Cycle
2-4 weeks